PPIA and delirium: CsA could reverse the development of delirium-like behavior by inhibiting CypA, and that short-term administration with low-dose CsA at 10 mg/kg may be a promising treatment for postoperative cognitive decline in mice (Peng et al., 2016; Zhang et al., 2018).